You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sertoli-Leydig Cell Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition

Recruiting
  • Pleuropulmonary Blastoma
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Dec 29, 2022

    Elucidating Genetic Basis of Pleuropulmonary Blastoma Familial

    Active, not recruiting
    • Pleuropulmonary Blastoma
    • +9 more
      • Washington, District of Columbia
        Children's National Medical Center
      Mar 9, 2022

      International PPB/DICER1 Registry

      Recruiting
      • Pleuropulmonary Blastoma
      • +14 more
        • Minneapolis, Minnesota
          Children's Minnesota
        Aug 16, 2022

        Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor Trial in United States (biological,

        Active, not recruiting
        Has Results
        • Ovarian Granulosa Cell Tumor
        • +6 more
        • Bleomycin Sulfate
        • +5 more
        • Anchorage, Alaska
        • +218 more
        Dec 30, 2021

        Malignant Ovarian Epithelial Tumor, Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma Trial in United States (Bevacizumab,

        Completed
        Has Results
        • Malignant Ovarian Epithelial Tumor
        • +7 more
        • Bevacizumab
        • Laboratory Biomarker Analysis
        • Los Angeles, California
        • +35 more
        Jul 19, 2019

        Adult Type Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor Trial in Japan, United

        Completed
        Has Results
        • Adult Type Ovarian Granulosa Cell Tumor
        • +4 more
        • Birmingham, Alabama
        • +97 more
        Feb 18, 2020

        Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States

        Recruiting
        • Bladder Adenocarcinoma
        • +45 more
        • Cabozantinib S-malate
        • +2 more
        • Birmingham, Alabama
        • +563 more
        Aug 24, 2022

        Spermatogenesis and Semen Disorders Trial in Hô` Chi´ Minh (FPT-20)

        Completed
        • Spermatogenesis and Semen Disorders
        • Hồ Chí Minh, Ho Chi Minh City, Vietnam
          Saigon Biopharma Company Limited
        May 26, 2022

        Urothelial Cancer and Rare Genitourinary Tract Malignancies

        Recruiting
        • Urothelial Cancer
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 23, 2023

          Aflatoxin Metabolites Concentration in Follicular Fluid on

          Not yet recruiting
          • Aflatoxin Poisoning
            • (no location specified)
            Jan 31, 2023

            RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)

            Recruiting
            • Cervical
              • Wuxi, Jiangsu, China
                Wuxi People's Hospital
              Jul 3, 2023

              LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

              Not yet recruiting
              • Relapsed Non-Hodgkin Lymphoma
                • (no location specified)
                Sep 19, 2023

                Serum Adrenal Androgens Among Prepubertal and Pubertal Boys With

                Not yet recruiting
                • Autism Spectrum Disorder
                • serum total testosterone, serum androsterone, serum androstenedione and serum dehydroepiandrosterone sulfate
                • +3 more
                • Sohag, Egypt
                  Sohag University Hospital
                Apr 12, 2023

                Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

                Not yet recruiting
                • Squamous Cell Carcinoma of the Skin
                • +2 more
                • Marlborough, Massachusetts
                  Phio Pharmaceuticals Corp.
                Aug 25, 2023

                Stage T3 Squamous Cell Carcinomas of the Scalp

                Active, not recruiting
                • Squamous Cell Carcinoma
                • +2 more
                  • Maastricht, Netherlands
                    Ellen Oyen
                  Aug 3, 2023

                  Autologous Natural Killer Cell Activity in Primary Cancer Cell

                  Recruiting
                  • Sarcoma
                    • Santa Monica, California
                      Sarcoma Oncology Research Center
                    May 19, 2023

                    Melanoma Trial (pembrolizumab, )

                    Active, not recruiting
                    Has Results
                    • Melanoma
                    • pembrolizumab
                    • placebo
                    • (no location specified)
                    Aug 18, 2022

                    Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

                    Not yet recruiting
                    • Lung Non-Small Cell Carcinoma
                    • Amivantamab
                    • +3 more
                    • (no location specified)
                    Oct 30, 2023

                    Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Rochester (Durvalumab, Radiation Therapy)

                    Not yet recruiting
                    • Lung Non-Small Cell Carcinoma
                    • Stage III Lung Cancer AJCC v8
                    • Durvalumab
                    • Radiation Therapy
                    • Rochester, Minnesota
                      Mayo Clinic in Rochester
                    Jan 4, 2023

                    Pediatric Germ Cell Tumor Trial in Seoul (TIP treatment (paclitaxel/ifosfamide/cisplatin))

                    Recruiting
                    • Pediatric Germ Cell Tumor
                    • TIP treatment (paclitaxel/ifosfamide/cisplatin)
                    • Seoul, Korea, Republic of
                      Yonsei University Health System, Severance Hospital
                    Jul 8, 2022

                    Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

                    Recruiting
                    • Metastatic Pancreatic Cancer
                    • MesoPher
                    • Mitazalimab
                    • Rotterdam, Zuid-Holland, Netherlands
                      Erasmus MC
                    Dec 6, 2022

                    Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

                    Recruiting
                    • Endometrial Cancer
                    • +8 more
                    • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
                    • Orlando, Florida
                    • +21 more
                    Feb 2, 2023

                    Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

                    Not yet recruiting
                    • Clinical Stage III Merkel Cell Carcinoma AJCC v8
                    • +5 more
                    • (no location specified)
                    Jul 13, 2023

                    Infiltrating Duct Carcinoma of the Breast

                    Not yet recruiting
                    • Invasive Breast Cancer
                      • (no location specified)
                      Jan 28, 2023

                      Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

                      Active, not recruiting
                      • Metastatic Lung Non-Small Cell Carcinoma
                      • +24 more
                      • 18F-Fluoromisonidazole
                      • +4 more
                      • La Jolla, California
                      • +15 more
                      Jan 3, 2023